Soon. In the fast lane, aston martin plans a fiveyear trade and investment drive in china worth over 600 Million Pounds. We will speak to the ceo, next. We are less than a halfhour from the start of european trading. Take a look at futures right now. We are seeing gains across the board on the major indexes with the exception of the ibex sorry, the ftse mib and stockholm. Here on the board, ftse futures gaining 0. 4 , dax futures up 0. 5 . Lets start with some of the earnings this morning. Roche expects sales growth to slow this year. It is counting on new drugs in the pipeline to offset revenue losses in its oncology medicine. Joining us from switzerland, the ceo of roche. Welcome to the program. Thanks for joining us. About 2018 as kind of the year of the cliff edge for drugmakers, for roche especially. How well do you think these new drugs in things like hemophilia are going to offset the loss of your cancer drugs . Im very confident. If you look at the growth in 2017, the vast majo
Nestle s CEO on Ozempic era: Nutritional needs are shifting
qz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from qz.com Daily Mail and Mail on Sunday newspapers.
Denmark s Economy Contracts With Drop in Pharma Production
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Ozempic maker Novo Nordisk says it will study drug s effects on alcohol consumption but isn t focused on addiction - Boston News, Weather, Sports
whdh.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from whdh.com Daily Mail and Mail on Sunday newspapers.